HPTN Publications
Looking to submit your manuscript for review?
Your manuscript can be reviewed by our Manuscript Review committee. Get the submission form.
Filter publications by:
El-Diwany R, Breitwieser FP, Soliman M, Skaist AM, Srikrishna G, Blankson JN, Ray SC, Wheelan SJ, Thomas DL, Balagopal A . Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals. AIDS. 2017, 31: 1405-1414
2017
AIDS
El-Sadr WM, Affrunti M, Gamble T, Zerbe A . Antiretroviral therapy: a promising HIV prevention strategy?. J Acquir Immune Defic Syndr. 2010, 55: 116-21
2010
J Acquir Immune Defic Syndr
HPTN 065
El-Sadr WM, Beauchamp G, Hall IH, Torian LV, Zingman BS, Lum G, Elion RA, Buchacz K, Burns D, Zerbe A, Gamble T, Donnell D, for the HPTN 065 Study Team . Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care. JAIDS.
2018
JAIDS
HPTN 065
El-Sadr WM, Serwadda DM, Sista N, Cohen MS . HIV prevention: great achievements, more challenges ahead. J Acquir Immune Defic Syndr. 2013, 63: S115-6
2013
J Acquir Immune Defic Syndr
Elbur AI, Donnell D, Hosek S, Dye B, Velloza J, Delany-Moretlwe S, Celum C . The Association Between Use of Adherence Support Interventions and Adherence to HIV Preexposure Prophylaxis Among Young South African and Zimbabwean Women in HPTN 082. AIDS Behav. 2025, 29: 2483-2494
2025
AIDS Behav
HPTN 082
Emory JF, Seserko LA, Marzinke MA . Development and bioanalytical validation of a liquid chromatographic-tandem mass spectrometric (LC-MS/MS) method for the quantification of the CCR5 antagonist maraviroc in human plasma. Clin Chim Acta. 2014, Apr 20: 198-205
2014
Clin Chim Acta
Eshleman SH, Fogel JM, Halvas EK, Piwowar-Manning E, Marzinke MA, Kofron R, Wang Z, Mellors J, McCauley M, Rinehart AR, Clair MS, Adeyeye A, Hinojosa JC, Cabello R, Middelkoop K, Hanscom B, Cohen MS, Grinsztejn B, Landovitz RJ, HPTN 083 Study Team . HIV RNA screening reduces integrase strand transfer inhibitor resistance risk in persons receiving long-acting cabotegravir for HIV prevention. J Infect Dis.
2022
J Infect Dis
HPTN 083
Eshleman SH, Fogel JM, Piwowar-Manning E, Chau G, Cummings V, Agyei Y, Richardson P, Sullivan P, Haines CD, Bushman LR, Petropoulos C, Persaud D, Kofron R, Hendrix CW, Anderson PL, Farrior J, Mellors J, Adeyeye A, Rinehart A, St Clair M, Ford S, Rooney JF . Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/ Emtricitabine for HIV Prevention: HPTN 084. J Infect Dis. 2022, 225: 1741-1749
2022
J Infect Dis
HPTN 084